Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 (GABA(A) Receptor Subunit Alpha 3 or GABRA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
May 2022	41	Global Markets Direct	ASDR-601537

Published: May 2022 - Pages : 41 - Publisher : Global Markets Direct - Report code : ASDR-601537

Baergic Bio Inc
Biocodex
Cerevel Therapeutics Holdings Inc
Engrail Therapeutics Inc
Saniona AB